QCM Cayman, Ltd.
- SEC CIK
- 0001166340
- Latest filing
- Nov 4, 2024
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by QCM Cayman, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q3 2024 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −32,446−100.0% | Sold out | Holders |
| Q3 2023 | 32,446 | $58.7K | 0.4% | +11,716+56.5% | Added | Holders |
| Q2 2023 | 20,730 | $38.6K | 0.2% | −16,240−43.9% | Reduced | Holders |
| Q1 2023 | 36,970 | $49.2K | 0.3% | +36,970 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −29,036−100.0% | Sold out | Holders |
| Q2 2022 | 29,036 | $69.0K | 1.2% | +29,036 | New | Holders |